[
  {
    "ts": null,
    "headline": "Here's Why Moderna (MRNA) Fell More Than Broader Market",
    "summary": "Moderna (MRNA) closed the most recent trading day at $26.68, moving 2.45% from the previous trading session.",
    "url": "https://finnhub.io/api/news?id=3c8a0b46d2fe601f16df62786a54c3ae67f6454d430c2cd1ae3eb3404c10ddac",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749851404,
      "headline": "Here's Why Moderna (MRNA) Fell More Than Broader Market",
      "id": 135257828,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Moderna (MRNA) closed the most recent trading day at $26.68, moving 2.45% from the previous trading session.",
      "url": "https://finnhub.io/api/news?id=3c8a0b46d2fe601f16df62786a54c3ae67f6454d430c2cd1ae3eb3404c10ddac"
    }
  },
  {
    "ts": null,
    "headline": "Oracle reports Q4 beat, BioNTech to acquire CureVac: Morning Buzz",
    "summary": "The major averages were mixed near noon with the Dow the laggard as a pullback in Boeing weighs on the Industrials index. U.S. initial jobless claims were unchanged at 248,000 in the week ended June 7, above expectations and holding at an eight-month high. Geopolitical concerns have also resurfaced; escalating tensions in the Middle East led to a sharp rise in oil prices and triggered safe-haven flows, which weighed on equities and the U.S. dollar. Meanwhile, U.S.-China trade progress continues",
    "url": "https://finnhub.io/api/news?id=69ca31e3f53b2667cbfeba800bb25441bc32a733cf113fcfd8f3818c4b4a61ae",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749831336,
      "headline": "Oracle reports Q4 beat, BioNTech to acquire CureVac: Morning Buzz",
      "id": 135254868,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "The major averages were mixed near noon with the Dow the laggard as a pullback in Boeing weighs on the Industrials index. U.S. initial jobless claims were unchanged at 248,000 in the week ended June 7, above expectations and holding at an eight-month high. Geopolitical concerns have also resurfaced; escalating tensions in the Middle East led to a sharp rise in oil prices and triggered safe-haven flows, which weighed on equities and the U.S. dollar. Meanwhile, U.S.-China trade progress continues",
      "url": "https://finnhub.io/api/news?id=69ca31e3f53b2667cbfeba800bb25441bc32a733cf113fcfd8f3818c4b4a61ae"
    }
  },
  {
    "ts": null,
    "headline": "Sector Update: Health Care Stocks Lean Lower Premarket Friday",
    "summary": "Health care stocks were leaning lower premarket Friday with the Health Care Select Sector SPDR Fund",
    "url": "https://finnhub.io/api/news?id=72525cb161dfc48b1e1974171338f2da768113333edfb38649e3d3819063f0f1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749820521,
      "headline": "Sector Update: Health Care Stocks Lean Lower Premarket Friday",
      "id": 135246198,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Health care stocks were leaning lower premarket Friday with the Health Care Select Sector SPDR Fund",
      "url": "https://finnhub.io/api/news?id=72525cb161dfc48b1e1974171338f2da768113333edfb38649e3d3819063f0f1"
    }
  },
  {
    "ts": null,
    "headline": "Moderna falls on fears new CDC vaccine advisory panel could cloud RSV shot prospects",
    "summary": "The RSV shot, mRESVIA, secured U.S. approval on Thursday for  use in at-risk adults aged 18 to 59 years, but needs the U.S. Centers for Disease Control and Prevention's recommendation before it is made available for the age group.  Earlier this week, Health Secretary Robert F. Kennedy Jr. fired all 17 members of the panel, known as the Advisory Committee on Immunization Practices (ACIP) - a move health experts warn could undermine public confidence in available vaccines.  The ACIP advises the CDC on who should get the shots after they are approved by the U.S. Food and Drug Administration.",
    "url": "https://finnhub.io/api/news?id=bcbaded9d8f0b5c2680d9c2f87d186104ac1c4e9b9db4d1e4764c88980f9b57b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749818546,
      "headline": "Moderna falls on fears new CDC vaccine advisory panel could cloud RSV shot prospects",
      "id": 135249653,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "The RSV shot, mRESVIA, secured U.S. approval on Thursday for  use in at-risk adults aged 18 to 59 years, but needs the U.S. Centers for Disease Control and Prevention's recommendation before it is made available for the age group.  Earlier this week, Health Secretary Robert F. Kennedy Jr. fired all 17 members of the panel, known as the Advisory Committee on Immunization Practices (ACIP) - a move health experts warn could undermine public confidence in available vaccines.  The ACIP advises the CDC on who should get the shots after they are approved by the U.S. Food and Drug Administration.",
      "url": "https://finnhub.io/api/news?id=bcbaded9d8f0b5c2680d9c2f87d186104ac1c4e9b9db4d1e4764c88980f9b57b"
    }
  },
  {
    "ts": null,
    "headline": "Moderna’s mRNA RSV vaccine wins expanded FDA approval for younger adults",
    "summary": "The label expansion for Moderna’s jab arrives at a juncture in America’s changing vaccine regulatory landscape.",
    "url": "https://finnhub.io/api/news?id=ad32726a950262774638dd7c2f3414228fd8646a214aefb4c0cdca3c21bf1fc2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749816892,
      "headline": "Moderna’s mRNA RSV vaccine wins expanded FDA approval for younger adults",
      "id": 135249655,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "The label expansion for Moderna’s jab arrives at a juncture in America’s changing vaccine regulatory landscape.",
      "url": "https://finnhub.io/api/news?id=ad32726a950262774638dd7c2f3414228fd8646a214aefb4c0cdca3c21bf1fc2"
    }
  },
  {
    "ts": null,
    "headline": "Moderna falls on doubts over new CDC panel's backing of RSV vaccine",
    "summary": "Moderna's shares fell 2.3%on Friday on concerns about whether a new CDC advisory panelwould back the use of the company's respiratory syncytial virusvaccine in a broader age group. ...",
    "url": "https://finnhub.io/api/news?id=0927f58ef6ebe88839d43665edf55d0c71a361b491d5d99016f624262090834e",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749807737,
      "headline": "Moderna falls on doubts over new CDC panel's backing of RSV vaccine",
      "id": 135252065,
      "image": "",
      "related": "MRNA",
      "source": "Finnhub",
      "summary": "Moderna's shares fell 2.3%on Friday on concerns about whether a new CDC advisory panelwould back the use of the company's respiratory syncytial virusvaccine in a broader age group. ...",
      "url": "https://finnhub.io/api/news?id=0927f58ef6ebe88839d43665edf55d0c71a361b491d5d99016f624262090834e"
    }
  },
  {
    "ts": null,
    "headline": "Moderna: expanded indication for RSV vaccine",
    "summary": "Moderna has announced that the FDA has approved 'mRESVIA' , its vaccine against respiratory syncytial virus , for the prevention of lower respiratory tract infections caused by RSV in adults aged 18...",
    "url": "https://finnhub.io/api/news?id=ef14ed500c8dcf98fb8c8ce36cfb238c308e0f718e58311fd69b2b3e0ff63d27",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749803533,
      "headline": "Moderna: expanded indication for RSV vaccine",
      "id": 135237565,
      "image": "",
      "related": "MRNA",
      "source": "Finnhub",
      "summary": "Moderna has announced that the FDA has approved 'mRESVIA' , its vaccine against respiratory syncytial virus , for the prevention of lower respiratory tract infections caused by RSV in adults aged 18...",
      "url": "https://finnhub.io/api/news?id=ef14ed500c8dcf98fb8c8ce36cfb238c308e0f718e58311fd69b2b3e0ff63d27"
    }
  },
  {
    "ts": null,
    "headline": "3 Healthcare Stocks with Questionable Fundamentals",
    "summary": "Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the industry’s returns - over the past six months, healthcare stocks have collectively shed 8.4%. This drawdown was discouraging since the S&P 500 held its ground.",
    "url": "https://finnhub.io/api/news?id=c2c48ca1f56230a746c61ba5bfd2be97bcccd06de8f9207fcc964df97565aff4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749789584,
      "headline": "3 Healthcare Stocks with Questionable Fundamentals",
      "id": 135242732,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the industry’s returns - over the past six months, healthcare stocks have collectively shed 8.4%. This drawdown was discouraging since the S&P 500 held its ground.",
      "url": "https://finnhub.io/api/news?id=c2c48ca1f56230a746c61ba5bfd2be97bcccd06de8f9207fcc964df97565aff4"
    }
  }
]